Marker

(redirected from prognostic marker)
Also found in: Dictionary, Thesaurus, Medical, Legal, Encyclopedia.

Marker

A slang term for documentation indicating that a debt is owed.
References in periodicals archive ?
External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma.
Survival rate was shorter in patients having-13/13 deletion accompanied by poor prognostic markers, including IGH rearrangements and P53 deletions, 3.
Other factors postulated as potential prognostic markers include: high-grade tumour volume, maximal tumour diameter, perineural invasion, DNA ploidy and molecular markers (E-cadherin, Ki-67, p53 expression).
N-cadherin as a novel prognostic marker of progression in superficial urothelial tumors.
Finally, if software algorithms are adjusted to enumerate pigment-containing leukocytes, the usefulness of this indicator as a prognostic marker (11) could be further evaluated.
PAPP-A has been suggested as a prognostic marker in patients with stable CAD as well as ACS (17-19).
3,4) Our laboratory participates in the CAP proficiency testing surveys, which include in situ hybridization as well as prognostic marker tissue microarrays for CD20, epidermal growth factor receptor, c-KIT (CD117), estrogen receptor, progesterone receptor, and human epidermal growth factor receptor (HER2/neu) IHC.
Anderson Cancer Center have identified a gene that may provide a new breast cancer prognostic marker.
We do need to correlate pretreatment patient characteristics with their CTC and PSA levels to come up with the best prognostic marker for hormone-refractory prostate cancer," Dr.
Agendia was the first to commercialize a diagnostic test - MammaPrint(R) - a prognostic marker to determine the risk assessment of breast cancer recurrence.
Given that uPAR(I) has been shown to be a strong prognostic marker for other cancers (15, 16, 18) and a potential diagnostic marker (19),it would be useful to measure the different uPAR forms in blood from healthy individuals adjusted for age and sex, to estimate a reference interval, and to test the utility of this new uPAR(I) assay in other cancer diseases.
Indeed, NT-proBNP "was consistently the strongest independent prognostic marker at predicting death or unplanned cardiovascular hospitalisations after baseline or follow-up assessment," said the authors,